Attention deficit/hyperactivity disorder. Attention-deficit hyperactivity disorders
Conditions
Sponsors
Sanandaj University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Years to 12 Years
Inclusion criteria
Inclusion criteria: Age between 6 -12 years Diagnosis of ADHD and ODD based on DSM5 without effective medication taking on mental status at least 2 weeks before the study
Exclusion criteria
Exclusion criteria: Intelectual disability based on clinical suspicious presence of uncontroled siezure Drug side effects and hypersensivity Recieving of any other drugs History of psychological disorder except for ADHD and ODD presence of medical deasese such as cardiac deaseses
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical Profile of illness reported by parents. Timepoint: Baselin , second,fourth and eighth weeks after intervention. Method of measurement: Canner's and ADHD Rating scales.;Symptoms severity reported by parents. Timepoint: Baselin , second ,fourth and eighth weeks after intervention. Method of measurement: ADHD Rating scale and CGI.;Efficacy of treatment. Timepoint: Baselin , second ,fourth and eighth weeks after intervention. Method of measurement: The Clinical Global Impressions (CGI) Scale used to rate the symptoms change over time, and efficacy of medication, taking into account the patient’s clinical condition by clinicians. | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug side effects. Timepoint: Second, fourth and eighth weeks after intervention. Method of measurement: checklist by clinical interview and exam. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Soleiman Mohammadzadeh
Sanandaj University of Medical Sciences
Outcome results
None listed